e-learning
resources
Munich 2014
Monday, 08.09.2014
Cells, biofilms and biomarkers in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Induction of the TGF-beta pseudoreceptor BAMBI by nontypeable haemophilus influenzae (NTHi) and its impact on TGF-beta induced effects
D. Wilpsbaeumer, K. Rohmann, J. Rupp, P. Zabel, S. Marwitz, T. Goldmann, K. Dalhoff, D. Droemann (Luebeck, Borstel, Germany)
Source:
International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Session:
Cells, biofilms and biomarkers in respiratory infections
Session type:
Thematic Poster Session
Number:
2496
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Wilpsbaeumer, K. Rohmann, J. Rupp, P. Zabel, S. Marwitz, T. Goldmann, K. Dalhoff, D. Droemann (Luebeck, Borstel, Germany). Induction of the TGF-beta pseudoreceptor BAMBI by nontypeable haemophilus influenzae (NTHi) and its impact on TGF-beta induced effects. Eur Respir J 2014; 44: Suppl. 58, 2496
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Viral infection of macrophages reduces CD36 expression: Implications for phagocytosis of non-typeable haemophilus influenzae
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015
Infection pattern and inflammatory response in acute and persistent nontypeable
haemophilus influenzae
(NTHi) infection of COPD lung tissue
Source: Eur Respir J 2006; 28: Suppl. 50, 841s
Year: 2006
Alteration of the immune response to nontypeable haemophilus influenzae (NTHI) during COPD exacerbation in mice
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Specific immune response against pseudomonas aeruginosa and haemophilus influenzae in severe COPD
Source: International Congress 2016 – Clinical and microbiological aspects of infections in COPD patients
Year: 2016
Effect of corticosteroids on epithelial cell response to non-typeable haemophilus influenzae
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Chronic infection by nontypeable
Haemophilus influenzae
fuels airway inflammation
Source: ERJ Open Res, 7 (1) 00614-2020; 10.1183/23120541.00614-2020
Year: 2021
Nontypeable
haemophilus influenzae
(NTHi) and lung oxidative stress
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Chronic bronchial infection/colonisation: aetiology and mechanisms
Source: Eur Respir Monogr 2013; 60: 34-45
Year: 2013
Clinical impact of a non-typeable Haemophilus influenzae (NTHi) adjuvanted vaccine in adults with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
Nontypeable Haemophilus influenzae infection of human lung tissue induces proinflammatory cytokine response via toll-like receptor 2 and EGF-receptor
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Macrophage inflammatory responses to Non-typeable Haemophilus influenzae (NTHi) are strain-dependent
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
Associations between haemophilus influenzae and levels of sputum antimicrobial peptides in COPD
Source: International Congress 2016 – Translational research in respiratory infections
Year: 2016
Identification of viable and non-viable haemophilus influenzae using qPCR
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Vitamin D-mediated expression of the antimicrobial peptide hCAP18/LL-37 and killing of non-typeable haemophilus influenzae (NTHi) is reduced after 14 days exposure to TNF-α and IL-1β in primary bronchial epithelial cells (PBEC)
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
Increased uptake of haemophilus influenzae by primary airway epithelial cells from COPD patients
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) adjuvanted vaccine in older adults with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
The persistence of Nontypeable Haemophilus Influenzae fuels type 17 immunity in the lung
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
Airway abundance of
Haemophilus influenzae
predicts response to azithromycin in adults with persistent uncontrolled asthma
Source: Eur Respir J, 56 (4) 2000194; 10.1183/13993003.00194-2020
Year: 2020
LATE-BREAKING ABSTRACT: Improving cell mediated immunity to non-typeable Haemophilus influenzae in children with chronic suppurative lung disease.
Source: International Congress 2014 – Respiratory infections in children
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept